INT CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY has a total of 13 patent applications. Its first patent ever was published in 2015. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets biotechnology, pharmaceuticals and environmental technology are MEDIMMUNE VACCINES INC, WISCONSIN ALUMNI RES FOUNDATION WARF and SEMENTIS LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 3 | |
#2 | WIPO (World Intellectual Property Organization) | 3 | |
#3 | EPO (European Patent Office) | 2 | |
#4 | United Kingdom | 2 | |
#5 | Brazil | 1 | |
#6 | China | 1 | |
#7 | Serbia | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Environmental technology | |
#4 | Computer technology | |
#5 | Measurement |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Microorganisms | |
#3 | Climate change adaptation technologies | |
#4 | Therapeutic chemical compounds | |
#5 | Peptides | |
#6 | Analysing materials | |
#7 | Bioinformatics | |
#8 | Measuring microorganism processes |
# | Name | Total Patents |
---|---|---|
#1 | Khanna Navin | 8 |
#2 | Ramasamy Viswanathan | 7 |
#3 | Arora Upasana | 2 |
#4 | Shukla Rahul | 2 |
#5 | Asif Mohmmed | 1 |
#6 | Viswanathan Ramasamy | 1 |
#7 | Shanmugam Rajgokul K | 1 |
#8 | Sheetal Kaul | 1 |
#9 | Kaul Sheetal | 1 |
#10 | Swaminathan Sathyamangalam | 1 |
Publication | Filing date | Title |
---|---|---|
WO2020208434A1 | Zika virus subunit vaccine | |
GB201907759D0 | Method for predicting treatment response for first line of tuberculosis drug regime | |
GB201906052D0 | Proteins with cardioprotective activity | |
WO2019064312A1 | Tetravalent dengue vaccine and processes thereof | |
CN110573185A | Micro RNA hsa-miR-665 in cardiac hypertrophy | |
US2017240601A1 | Tetravalent dengue vaccine |